SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008741
Filing Date
2022-05-10
Accepted
2022-05-10 08:16:53
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q phat-20220331.htm   iXBRL 10-Q 1788883
2 EX-10.1 phat-ex10_1.htm EX-10.1 147999
3 EX-31.1 phat-ex31_1.htm EX-31.1 17040
4 EX-31.2 phat-ex31_2.htm EX-31.2 17277
5 EX-32.1 phat-ex32_1.htm EX-32.1 10796
6 EX-32.2 phat-ex32_2.htm EX-32.2 11009
7 GRAPHIC img229110809_0.jpg GRAPHIC 9568
8 GRAPHIC img229110809_1.jpg GRAPHIC 4702
  Complete submission text file 0000950170-22-008741.txt   7580154

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phat-20220331_def.xml EX-101.DEF 241092
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phat-20220331_cal.xml EX-101.CAL 40369
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phat-20220331.xsd EX-101.SCH 64257
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phat-20220331_pre.xml EX-101.PRE 370023
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phat-20220331_lab.xml EX-101.LAB 522871
55 EXTRACTED XBRL INSTANCE DOCUMENT phat-20220331_htm.xml XML 1201242
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 22907487
SIC: 2834 Pharmaceutical Preparations